Genmab — Oktober 2018
-
POLLUX update Hematologia 20. sept...https://www.ncbi.nlm.nih.gov/pubmed/30237262
-
51,2% CR og 92.9% ORR siger vidst alt
-
CASTOR update Haematologica 20. sept ...free article...https://www.ncbi.nlm.nih.gov/pubmed/30237264
-
Deutsche Bank: Forventer Darzalex salg på USD 563M for Q3 (Q2 var 511)
-
The unique immunomodulatory characteristics of the CD38 target molecule and its downregulation by daratumumab-mediated trogocytosis may actually be one of the explanations that daratumumab is the first monoclonal antibody with single agent activity in MM..vdDong..https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154747/ ...fri artikel
-
In the reported 3 patients with life-threatening posttransplant AIHA, daratumumab was curative in 2, with the third showing a transient response before relapse of AIHA 8 months after this therapy. The survivors are currently free of any signs of hemolysis with a follow-up of 18 and 13 months after administration of daratumumab....http://www.bloodadvances.org/content/2/19/2550.long?sso-checked=true
-
Deutsche Bank mener at væksten i USA nu er nede på 3% (Q2 til Q3). Så hele væksten skal komme fra RoW. De mener ikke der vil være nogen nævneværdig 1. linie salg fra Europa....
-
Bulder - har du taget 14% fra US recepttallene i dine beregninger?
-
med uændret vækst i RoW på 23% får jeg et tal lige syd for usd 560 mio
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind